MedPath

INSTITUT PASTEUR DE DAKAR

🇸🇳Senegal
Ownership
-
Established
1896-01-01
Employees
-
Market Cap
-
Website
http://www.pasteur.sn

Clinical Trials

4

Active:0
Completed:0

Trial Phases

3 Phases

Phase 2:1
Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 2
1 (33.3%)
Phase 3
1 (33.3%)

Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal

Not yet recruiting
Conditions
Measles
First Posted Date
2023-05-16
Last Posted Date
2025-05-13
Lead Sponsor
Institut Pasteur de Dakar
Target Recruit Count
850
Registration Number
NCT05860920

Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal

Phase 2
Recruiting
Conditions
Environmental Enteric Dysfunction
Interventions
Device: CapScan®
Drug: Placebo
First Posted Date
2022-08-15
Last Posted Date
2025-05-13
Lead Sponsor
Institut Pasteur de Dakar
Target Recruit Count
76
Registration Number
NCT05501470
Locations
🇸🇳

Centre de santé de Wakhinane, Guédiawaye, Dakar, Senegal

Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal

Phase 3
Terminated
Conditions
COVID-19
Interventions
First Posted Date
2020-05-15
Last Posted Date
2024-06-21
Lead Sponsor
Institut Pasteur de Dakar
Target Recruit Count
59
Registration Number
NCT04390594
Locations
🇸🇳

Infectious and Tropical Diseases Department, Fann Hospital, Dakar, Senegal

🇸🇳

Diamniadio Children Hospital, Diamniadio, Senegal

🇸🇳

Dalal Jamm Hospital, Guédiawaye, Senegal

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.